Senti Bioscience News Today

Quince Therapeutics (NASDAQ:QNCX – Get Free Report) and Senti Biosciences (NASDAQ:SNTI – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. Insider & Institutional Ownership 39.6% of Quince […]

Inhibikase Therapeutics (NYSE:IKT – Get Free Report) and Senti Biosciences (NASDAQ:SNTI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends. Institutional and Insider Ownership 14.0% of Inhibikase […]

WuXi Biologics (Cayman) (OTCMKTS:WXXWY – Get Free Report) and Senti Biosciences (NASDAQ:SNTI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability. Analyst Ratings This is a breakdown of […]

GeneFab, which acquired Senti Biosciences' lease for the space as part of a $38 million deal, says its plans for the facility go beyond its own products.

Senti Biosciences, Inc. (NASDAQ:SNTI – Free Report) – Equities researchers at Chardan Capital lowered their FY2023 EPS estimates for shares of Senti Biosciences in a report issued on Tuesday, August 15th. Chardan Capital analyst Y. Livshits now expects that the company will earn ($1.05) per share for the year, down from their prior estimate of […]

Senti Biosciences (NASDAQ:SNTI – Get Rating) is one of 271 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare Senti Biosciences to similar companies based on the strength of its earnings, profitability, analyst recommendations, dividends, institutional ownership, risk and valuation. Profitability This table compares […]

Senti Biosciences (NASDAQ:SNTI – Get Rating) is one of 280 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare Senti Biosciences to similar businesses based on the strength of its valuation, dividends, risk, earnings, analyst recommendations, institutional ownership and profitability. Earnings & Valuation This […]

Senti Biosciences (NASDAQ:SNTI – Get Rating) is one of 283 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its rivals? We will compare Senti Biosciences to similar companies based on the strength of its institutional ownership, earnings, analyst recommendations, dividends, risk, profitability and valuation. Analyst Ratings This is […]